Literature DB >> 32259853

Nuclear medicine in SARS-CoV-2 pandemia: 18F-FDG-PET/CT to visualize COVID-19.

Susanne Lütje1, Milka Marinova2, Daniel Kütting2, Ulrike Attenberger2, Markus Essler1, Ralph Alexander Bundschuh1.   

Abstract

The current outbreak of coronavirus SARS-CoV-2 has reached multiple countries worldwide. While the number of newly diagnosed cases and fatalities is rising quickly, far-reaching measures were enacted to prevent further spread. Diagnosis relies on clinical presentation, exposure history, PCR using specimens from the respiratory tract together with computed tomography (CT) imaging. One of the hallmarks of a critical course of COVID-19 is the development of severe acute respiratory distress syndrome (ARDS). As management of COVID-19 can be considered a multi-disciplinary approach involving various medical specialties, we here review the first 18F-FDG-PET/CT scans of COVID-19 to discuss how Nuclear Medicine could contribute to management of this disease. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32259853     DOI: 10.1055/a-1152-2341

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  23 in total

1. 

Authors:  Reshma Amin; Leonard Grinblat; Mansoor Husain
Journal:  CMAJ       Date:  2020-11-09       Impact factor: 8.262

2.  [18F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae].

Authors:  B Rodríguez-Alfonso; S Ruiz Solís; L Silva-Hernández; I Pintos Pascual; S Aguado Ibáñez; C Salas Antón
Journal:  Rev Esp Med Nucl Imagen Mol       Date:  2021-07-12       Impact factor: 1.359

3.  68 Ga-DOTATATE Uptake in COVID-19 Pneumonia: A Non-Neoplastic False Positive.

Authors:  Joshua P Weissman; Twyla Bartel
Journal:  World J Nucl Med       Date:  2022-07-19

4.  [18F]FDG PET/CT in Short-Term Complications of COVID-19: Metabolic Markers of Persistent Inflammation and Impaired Respiratory Function.

Authors:  Eva María Triviño-Ibáñez; Beatriz María Jiménez-Rodríguez; Teodoro Rudolphi-Solero; Encarnación Yolanda García-Rivero; Antonio Rodríguez-Fernández; José Manuel Llamas-Elvira; Manuel Gómez-Río; Concepción Morales-García
Journal:  Diagnostics (Basel)       Date:  2022-03-29

Review 5.  Highlighting COVID-19: What the imaging exams show about the disease.

Authors:  Lorena Sousa de Carvalho; Ronaldo Teixeira da Silva Júnior; Bruna Vieira Silva Oliveira; Yasmin Silva de Miranda; Nara Lúcia Fonseca Rebouças; Matheus Sande Loureiro; Samuel Luca Rocha Pinheiro; Regiane Santos da Silva; Paulo Victor Silva Lima Medrado Correia; Maria José Souza Silva; Sabrina Neves Ribeiro; Filipe Antônio França da Silva; Breno Bittencourt de Brito; Maria Luísa Cordeiro Santos; Rafael Augusto Oliveira Sodré Leal; Márcio Vasconcelos Oliveira; Fabrício Freire de Melo
Journal:  World J Radiol       Date:  2021-05-28

Review 6.  Covid-19 imaging: A narrative review.

Authors:  Hanae Ramdani; Nazik Allali; Latifa Chat; Siham El Haddad
Journal:  Ann Med Surg (Lond)       Date:  2021-06-18

Review 7.  Medical imaging and computational image analysis in COVID-19 diagnosis: A review.

Authors:  Shahabedin Nabavi; Azar Ejmalian; Mohsen Ebrahimi Moghaddam; Ahmad Ali Abin; Alejandro F Frangi; Mohammad Mohammadi; Hamidreza Saligheh Rad
Journal:  Comput Biol Med       Date:  2021-06-23       Impact factor: 6.698

8.  Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey.

Authors:  Salvatore Annunziata; Matteo Bauckneht; Domenico Albano; Giovanni Argiroffi; Diletta Calabrò; Elisabetta Abenavoli; Flavia Linguanti; Riccardo Laudicella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-27       Impact factor: 9.236

9.  18F-FDG PET/CT Metabolic Behavior of COVID-19 Pneumonia: A Series of 4 Patients With RT-PCR Confirmation.

Authors:  Domenico Albano; Luca Camoni; Roberto Rinaldi; Francesco Bertagna; Raffaele Giubbini
Journal:  Clin Nucl Med       Date:  2020-08       Impact factor: 10.782

10.  A theranostic approach based on radiolabeled antiviral drugs, antibodies and CRISPR-associated proteins for early detection and treatment of SARS-CoV-2 disease.

Authors:  Isaac Shiri; Hamid Abdollahi; Mohammad Reza Atashzar; Arman Rahmim; Habib Zaidi
Journal:  Nucl Med Commun       Date:  2020-09       Impact factor: 1.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.